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Background: Epithelial mesenchymal transition (EMT) is involved in the pathogenesis of adenomyosis, and Notch
signaling is crucial to EMT. The objective of this study was to explore Notch1/Numb/Snail signaling in adenomyosis.
Methods: The expression levels of the members of the Notch1/Numb/Snail signaling cascade in normal
endometria (proliferative phase: n = 15; secretory phase: n = 15; postmenopausal phase: n = 15) and adenomyotic
endometria (proliferative phase: n = 15; secretory phase: n = 15) were determined by immunohistochemistry
analysis.
Results: We found that the expressions of Notch1 and the EMT-related proteins N-cadherin, Snail and Slug were
upregulated in the ectopic endometrium of adenomyosis compared with normal endometrium. Numb, a negative
regulator of Notch signaling, was significantly decreased in adenomyosis. In addition, reduced immunoexpression
of E-cadherin was observed in adenomyosis.
Conclusions: We conclude that Notch1/Numb/Snail signaling plays an important role in the pathogenesis and
development of adenomyosis.
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Adenomyosis is a prevalent gynaecologic benign condition
of the uterus characterized by the presence of activated
endometrium within the myometrium [1]. The disease
leads to dysmenorrhea, dyspareunia, abnormal uterine
bleeding, and infertility and significantly reduces the qual-
ity of life of women of reproductive age [2]. The best treat-
ment for adenomyosis is still unclear, and the mechanism
of thisdisease has not been determined.
Epithelial-mesenchymal transition (EMT) is a biological
process during which epithelial cells lose their polarity
and cell-cell contacts and acquire a migratory mesenchy-
mal phenotype [3, 4]. The process of EMT is characterized
by the loss of epithelial markers and the acquisition of* Correspondence: huizhang1218@126.com
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otherwise stated.mesenchymal markers [5]. The EMT plays a key role in
tumour metastasis [6].
Migration and invasion are also considered key to the
formation and progression of endometriosis [7]. Recent
studies have shown that EMT-like processes may be in-
volved in the pathogenesis of endometriosis [8, 9]. Weaker
expression of epithelial markers and stronger expression
of mesenchymal markers are present in ectopic epithelial
cells of endometriotic lesions on peritoneal and ovarian
tissues [8]. In the epithelial component of adenomyotic le-
sions, vimentin expression is up-regulated and E-cadherin
expression is down-regulated compared to the eutopic
endometrium [10].
The Notch signaling pathway is thought to be critical
for the induction of EMT. The Notch family, which in-
cluded four members, Notch1-4, is a family of single-
pass transmembrane receptor proteins [11]. Mature
Notch receptors are heterologous dimers, consisting of a
large extracellular ligand binding domain, a single-passdistributed under the terms of the Creative Commons Attribution 4.0
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Table 1 Detailed information of patients
Proliferative phase Secretory phase
Ages Dysmenorrhea Ages Dysmenorrhea
39 + 47 +
44 + 41 +
47 + 50 +
44 + 45 +
45 + 42 +
43 + 42 +
32 + 47 +
47 + 37 +
37 + 40 +
43 + 48 +
47 + 43 +
44 - 52 +
49 + 45 +
39 + 48 +
50 + 51 +
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unit (Notch intracellular domain, NICD) [12, 13].Trans-
membrane ligands of the DSL (Delta/Serrate/Lag2) family
bind to Notch receptors, triggering heterodimer cleavage
and release of the NICD. The NICD then enters the
nucleus and modulates the transcription of downstream
target genes, including EMT-related genes, such as Snail
and Slug (also called Snail2) [13]. Snail and Slug can com-
bine with the E-cadherin promoter to suppress its expres-
sion [14, 15]. Numb is an inhibitory regulator of Notch1
signaling that acts by promoting the ubiquitination and
degradation of the Notch1 intracellular domain [16]. It
has been reported that down-regulation or loss of Numb
expression might be correlated with the genesis, develop-
ment and enhancement of the invasion of multiple tu-
mours [17, 18].
Notch signaling is involved in the process of EMT in a
series of human tumours. Notch signaling can promote
TGF-β1-induced EMT through the induction of Snai1
[19]. In various human cancer models, Jagged1-mediated
notch signaling activation can elevate the expressions of
Snail and Slug, resulting in the repression of E-cadherin
[20]. In pancreatic cancer cells, over-expression of Notch-
1 induces the EMT phenotype and increases cell growth,
migration and invasion [21]. In lung cancer cells, inhib-
ition of Notch signaling reverses the EMT process and,
thus, enhances the therapeutic susceptibility of lung
cancer cells [22]. In breast cancer cells, anti-human NICD
monoclonal antibody can suppress the EMT process,
inhibit cell growth and induce apoptosis [23]. Hypoxia-
induced Notch signaling can affect EMT and migration of
breast cancer cells by regulating the expression of Snail
and Slug [24]. Moreover,Notch signaling can regulate the
progression of metastatic hepatocellular carcinoma by
regulating the expression of Snail and E-cadherin [25].
As shown above, Notch signaling cascades are crucial in
the process of EMT. In the current study, we aimed to
investigate the status of Notch1/Numb/Snail signaling in
adenomyosis and to explore the possible role of this
signaling pathway in the development and progression
of this disease.
Methods
Materials and tissue collection
Rabbit anti-human Notch1 (NICD); mouse anti-human
Numb, E-cadherin, N-cadherin, and Slug; and goat anti-
human Snail primary antibodies were obtained from
Abcam (Beverly, MA, USA). Goat anti-rabbit and goat
anti-mouse HRP-conjugated secondary antibodies and
Diaminobenzidine staining kits were obtained from
ZSGB-BIO (Beijing, China).
Normal endometria were obtained from 45 women of re-
productive age undergoing bilateral tubal ligation (prolifera-
tive phase: n = 15; secretory phase: n = 15; postmenopausalphase: n = 15). Adenomyotic lesions were obtained from 30
patients with adenomyosis undergoing hysterectomy or
subtotal hysterectomy (proliferative phase: n = 15; secretory
phase: n = 15) (Table 1). Normal endometria and adeno-
myosis tissues were collected during the operation.The
diagnosis of adenomyosis was confirmed by histological
examination. No patients received any hormonal therapy in
three months prior to their surgery. Informed consent was
obtained from all participants prior to the biopsy proced-
ure, and the use of human tissues was approved by the in-
stitutional review board of Shandong Provincial Hospital
Affiliated to Shandong University.
Immunohistochemistry analysis
Immunohistochemistry analysis was performed on normal
endometria and adenomyotic lesions. Fresh tissue samples
were washed with PBS twice to remove blood. Then, they
were fixed in 4 % paraformaldehyde for 24 h and embed-
ded in paraffin. The samples were cut into 4 μm sections
and mounted onto glass slides. Deparaffinized,rehydrated
sections were incubated with 3 % H2O2 for 30 min to
block endogenous peroxidase activity. Antigen retrieval
was performed using a pressure-cooker for 90 seconds
inEDTA buffer at pH 7.6. The sections were rinsed in
PBS, blocked with 10 % normal goat serum or calf serum
for 30 min,and then incubated with primary antibodies,
including rabbit anti-human notch(diluted 1:200 in PBS),
mouse anti-human numb (diluted 1:150 in PBS), E-
cadherin (diluted 1:100 in PBS), N-cadherin (diluted 1:500
in PBS), Slug (diluted 1:150 in PBS) andgoat anti-human
snail (diluted 1:100 in PBS)antibodies, overnight in a wet
chamber at 4 °C. HRP-conjugated goat anti-rabbit or
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ate. HRP activity was detected by measuring the level of
the substrate diaminobenzidine tetrahydrochloride (DAB)
for 1 min. The sections were counterstained with haema-
toxylin before mounting. Sections incubated with non-
immune serum instead of primary antibodies were used as
the negative controls. The sections were observed under a
Leica DM4000B microscope (Leica), and pictures were
taken using the IM50 image analysis system (Leica).
The immunostaining was expressed as immunoscore-
H-score, which was semiquantitative as a product of a
quantity score and a staining intensity. The quantity score
was estimated as follows: four random views are chosen
and 100 cells were counted to get the percentages (Pi) of
positively stained glandular epithelial cells. The staining
intensity (I) of the glandular epithelial cells was estimated
as follows: 0: negative; 1: weak staining; 2: moderate stain-
ing; and 3: strong staining. Two sections per sample were
assessed by two observers. H-score = Pi (I + 1). All slides
were evaluated for immunostaining without any know-
ledge of the clinical or pathological data.
Statistical analysis
The data were statistically analysed by the two-tailed stu-
dent’s unpaired t-test using SPSS 19.0 (SPSS Inc., Chicago,
IL). Values are expressed as means ± SD. Differences be-
tween two groups were determined by the two-tailed
student’s t-test. The level of statistical significance was set
at p < 0.05.
Results
Notch1 expression was upregulated in adenomyosis
The expression of Notch1 in normal endometria and
ectopic endometria from adenomyotic lesions was deter-
mined using immunohistochemical analysis. As shown in
Fig. 1, in normal endometria, the staining of Notch1 wasFig. 1 Immunoexpression of protein Notch1 in normal endometrium and
endometrium of proliferative phase (n = 15); b normal endometrium of sec
phase (n = 15); d ectopic endometrium in adenomyosis of proliferative pha
(n = 15); magnification: ×200; f Immunoscore of Notch1weakly positive or positive and was concentrated in the
cytoplasm of endometrial epithelial cells (Fig. 1, a-c). In
stromal cells, the immunostaining of Notch1 was very
weak. Endometria in the proliferative phase showed higher
Notch1 expression than endometria in the secretory phase
(Fig. 1a-b, p < 0.01). No significant difference in Notch1 ex-
pression was noted between endometria in the productive
phase and endometria in the postmenopausal phase
(Fig. 1a-c, p > 0.05).
In ectopic endometria of adenomyosis, the immuno-
staining of Notch1 was strongly positive and was also
restricted to the cytoplasm of epithelial cells (Fig. 1d, e);
weak immunostaining was observed in stromal cells. In
addition, no significant difference in Notch1 expression
was observed between ectopic endometria in the prolifera-
tive and secretory phases (Fig. 1d-e, p > 0.05). However,
ectopic endometria of adenomyosis in both the prolifera-
tive and secretory phases showed significantly increased
Notch1 expression compared to normal endometria
(Fig. 1f, p < 0.01).
These data suggest that elevated Notch1 signaling is
present in adenomyosis. Moreover, Notch1 expression
was shown to change during the menstrual cycle in nor-
mal endometria but not in adenomyotic endometria.Numb expression was reduced in adenomyosis
The expression of Numb in different endometria was
determined by immunohistochemical analysis. As shown
in Fig. 2, in normal endometria, the immunostaining of
Numb was strongly positive and was most frequently
distributed in the cytoplasm of endometrial epithelial cells;
immunostaining in stromal cells was very weak. No sig-
nificant difference in Numb expression was observed be-
tween endometria in the proliferative, secretory and
postmenopausal phases (Fig. 2a-c, p > 0.05).ectopic endometrium from patients with adenomyosis. a normal
retory phase (n = 15); c normal endometrium of postmenopausal
se (n = 15); e ectopic endometrium in adenomyosis of secretory phase
Fig. 2 Immunoexpression of protein Numb in normal endometrium and ectopic endometrium from patients with adenomyosis. a normal
endometrium of proliferative phase (n = 15); b normal endometrium of secretory phase (n = 15); c normal endometrium of postmenopausal
phase (n = 15); d ectopic endometrium in adenomyosis of proliferative phase (n = 15); e ectopic endometrium in adenomyosis of secretory phase
(n = 15); magnification: ×200; f Immunoscore of Numb
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staining of Numb was weakly positive and was restricted
to the cytoplasm of epithelial cells (Fig. 2d, e); weak im-
munostaining was observed in stromal cells. In addition,
no significant difference in Numb expression was ob-
served in ectopic endometria in the proliferative and
secretory phases (Fig. 2d, e, p > 0.05). However, ectopic en-
dometria of adenomyosis showed significantly decreased
Numb expression in both the proliferative and secretory
phases compared with normal endometria (Fig. 2d, e, p <
0.05).
These data suggest that Numb expression did not change
during the menstrual cycles in either normal endometria or
adenomyotic endometria and that Numb expression was
lost in adenomyosis.Fig. 3 Immunoexpression of protein Snail in normal endometrium and ect
endometrium of proliferative phase (n = 15); b normal endometrium of sec
phase (n = 15); d ectopic endometrium in adenomyosis of proliferative pha
(n = 15); magnification: ×200; f Immunoscore of SnailSnail expression was increased in adenomyosis
The expression of Snail in different endometria was deter-
mined using immunohistochemical analysis. As shown in
Fig. 3, in normal endometria, the immunostaining of Snail
was negative or weakly positive and was restricted to the
nucleus of endometrial glandular epithelial cells; immuno-
staining in stromal cells was very weak. Endometria in the
proliferative and postmenopausal phases showed de-
creased Snail expression compared with endometria in
thesecretory phase (Fig. 3a-c, f, p < 0.01). No significant
difference in Snail expression was observed between endo-
metria in the productive and postmenopausal phases
(Fig. 3a-c, f, p > 0.05).
In ectopic endometria of adenomyosis, the immuno-
staining of Snail was strongly positive and was restrictedopic endometrium from patients with adenomyosis. a normal
retory phase (n = 15); c normal endometrium of postmenopausal
se (n = 15); e ectopic endometrium in adenomyosis of secretory phase
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nostaining was observed in stromal cells. No significant
difference in Snail expression was observed between ec-
topic endometria in the proliferative and secretory phases
(Fig. 3d-f, p > 0.05); however, ectopic endometria of ade-
nomyosis showed significantly increased Snail expression
in both the proliferative and secretory phases compared
with normal endometria(Fig. 3a-f, p < 0.01).
These data suggest that Snail expression is elevated in
adenomyosis. In addition, Snail expression changed during
the menstrual cycle in normal endometriabut not in ade-
nomyotic endometria.Slug expression was upregulated in adenomyosis
The expression of Slug in different endometria was deter-
mined by immunohistochemical analysis. As shown in
Fig. 4, in normal endometria, the immunostaining of Slug
was weakly positive or positive and was usually distributed
in the cell membrane of endometrial epithelial cells; im-
munostaining in stromal cells was very weak. No signifi-
cant difference in Slug expression was observed between
endometria in the proliferative, secretory and postmeno-
pausal stages (Fig. 4a-c, p > 0.05).
In ectopic endometria of adenomyosis, the immuno-
staining of Slug was also strongly positive and was
restricted to the cell membrane of epithelial cells; weaker
immunostaining was observed in stromal cells. No signifi-
cant difference in Slug expression was observed between
ectopic endometria in the proliferative and secretory
phases (Fig. 4d-f, p > 0.05); however, ectopic endometria of
adenomyosis in both the proliferative and secretory phases
showed significantly increased Slug expression compared
with normal endometria (Fig. 4d-f, p < 0.01).
These data suggest that Slug expression did not change
during the menstrual cycle in either normal endometria orFig. 4 Immunoexpression of protein Slug in normal endometrium and ect
endometrium of proliferative phase (n = 15); b normal endometrium of sec
phase (n = 15); d ectopic endometrium in adenomyosis of proliferative pha
(n = 15); magnification: ×200; f Immunoscore of Slugadenomyotic endometria and that Slug expression was
increased in adenomyosis.
N-cadherin expression was upregulated in adenomyosis
The expression of N-cadherin in different endometria was
determined by immunohistochemical analysis. As shown
in Fig. 5, in normal endometria, the immunostaining of
N-Cadherin was weakly positive or positive and was usu-
ally distributed in the membrane of endometrial epithelial
cells; immunostaining in stromal cells was very weak.
Endometria in the secretory and postmenopausal phases
showed higher N-cadherin expression than endometria in
the proliferative phase (Fig. 5a-b, p < 0.05). No significant
difference in N-cadherin expression was observed be-
tween endometria in the secretory and postmenopausal
phases (Fig. 5a-c, p > 0.05).
In ectopic endometria of adenomyosis, the immuno-
staining of N-cadherin was strongly positive and was
restricted to the cytoplasm of epithelial cells (Fig. 5d,
e); weak immunostaining was observed in stromal cells.
No significant difference inN-cadherin expression was
observed between ectopic endometria in the prolifera-
tive and secretory phases (Fig. 5d-f, p > 0.05); however,
ectopic endometria of adenomyosis in both the proliferative
and secretory phases showed significantly increased N-
cadherin expression compared with normal endometria
(Fig. 5f, p < 0.01).
These data suggest that elevated N-cadherin expression
is present in adenomyosis. N-cadherin expression changed
during the menstrual cycles in normal endometria but not
in adenomyotic endometria.
E-cadherin expression was downregulated in
adenomyosis
The expression ofE-cadherinin different endometria was
determined by immunohistochemical analysis. As shownopic endometrium from patients with adenomyosis. a normal
retory phase (n = 15); c normal endometrium of postmenopausal
se (n = 15); e ectopic endometrium in adenomyosis of secretory phase
Fig. 5 Immunoexpression of protein N-Cadherin in normal endometrium and ectopic endometrium from patients with adenomyosis. a normal
endometrium of proliferative phase (n = 15); b normal endometrium of secretory phase (n = 15); c normal endometrium of postmenopausal phase
(n = 15); d ectopic endometrium in adenomyosis of proliferative phase (n = 15); e ectopic endometrium in adenomyosis of secretory phase
(n = 15); magnification: ×200; f Immunoscore of N-Cadherin
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of E-cadherin was strongly positive and was usually
distributed in the membrane of endometrial epithelial
cells; immunostaining in stromal cells was very weak.
No significant difference of E-cadherin expression was
observed between the endometria in different phases
(Fig. 6a-c, f, p > 0.05).
In ectopic endometria of adenomyosis, the immuno-
staining of E-cadherin was weakly positive and was
restricted to the membrane of epithelial cells (Fig. 6d, e);
weak immunostaining was observed in stromal cells. Ec-
topic endometria in the proliferative phase showed
higher E-cadherin expression than ectopic endometria in
the secretive phase (Fig. 6d-f, p < 0.01). In addition, ec-
topic endometria of adenomyosis showed significantly
decreased E-cadherin expression in both the proliferative
and secretory phases compared with normal endometria
(Fig. 6d-f, p < 0.05).Fig. 6 Immunoexpression of protein E-Cadherin in normal endometrium a
endometrium of proliferative phase (n = 15); b normal endometrium of sec
(n = 15); d ectopic endometrium in adenomyosis of proliferative phase (n =
(n = 15); magnification: ×200; f Immunoscore of E-CadherinThese data indicate that reduced E-cadherin expression
is present in adenomyosis.
Discussion
Adenomyosis is adisease that exists independent from
endometriosis [2]. The main pathological changes of ade-
nomyosis are the invasion of functional endometrial
glands and stroma into the myometrium and the growth
of ectopic glands or stroma in the myometrium and/or
local hyperplasia [1]. Although adenomyosis is a benign
disease, it exhibits a series of biological behaviours that
are similar to those of malignant tumours, including adhe-
sion, invasion, and implantation [26]. EMT is a process
during which epithelial cells undergo phenotypic trans-
formation into mesenchymal cells [5]. A great dealof evi-
dence indicates that EMT is associated with the invasive
and migratory behaviours of cancer cells, which enhance
the metastatic ability of these cells [6, 7]. Chen et al.nd ectopic endometrium from patients with adenomyosis. a normal
retory phase (n = 15); c normal endometrium of postmenopausal phase
15); e ectopic endometrium in adenomyosis of secretory phase
Fig. 7 Schematic representation of Notch1/Numb/Snail signaling-induced EMT in adenomyosis
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adenomyosis [10]. In the current study, we found that the
EMT-related Notch1/Numb/Snail signaling pathway plays
an important role in the pathogenesis of adenomyosis.
Notch signalingis involved in cell proliferation, survival,
apoptosis, and differentiation, and alterations in Notch
signaling are linked to tumourigenesis [27]. Notch activa-
tion in endothelial cells results in the down-regulation of
endothelial markers and the up-regulation of mesenchy-
mal markers [28]. In the EMT process, Notch signaling-
crosstalks with multiple transcription and growth factors
that are relevant to EMT, such as Snail, Slug, TGF-β, FGF,
and PDGF [29, 30].
In human endometrium, Notch1-3 are expressed not
only stromal cells but also in glandular epithelial cells, and
Jagged and DDL4 are mainly expressed in glandular epi-
thelial cells [31]. Mori et al. reported that the expression
of Notch1 in the endometrium is higher during the prolif-
erative phase than the secretory phase and is lowest dur-
ing the postmenopausal phase [32]. In contrast, Cobellis
et al. found that the expressions of Notch1 and Jagged1 in-
creased from the proliferative phase to the secretory phase
[33]. Notch1 plays an important role in the differentiation
and decidualization of endometrial stromal cells [34]. Dur-
ing this process, the expression of Notch1 is down-
regulated and the expression of Numb is up-regulated
[35]. In endometrial carcinoma, the expressions of Notch,
Jagged1, and DLL4 are significantly increased and are re-
lated to the stage and prognosis of the disease, and block-
age of the Notch signaling pathway significantly inhibits
the growth and invasion of endometrial adenocarcinoma
cells [32, 36]. In addition, blockage of Notch signaling in-
duces apoptosis in Ishikawa cells [37], while increased
oestrogen promotes the growth of Ishikawa cells by acti-
vating the Notch signaling pathway [38]. In the current
study, elevated Notch1 expression was noted in adeno-
myosis, suggesting its significant role in this disease. We
found that endometrium in the proliferative phase showed
higher Notch1 expression than that in the secretory phaseand that endometrium in the postmenopausal phase
showed the lowest level of Notch1 expression. These data
are consistent with those of the study by Mori et al. More-
over, in our study, Notch1 expression changed during the
menstrual cycle in normal endometria but not in adeno-
myotic endometria. These data indicate that of Notch1
expression in normal endometrium is regulated by hor-
mones and that this hormonal sensitivity is aberrant in
adenomyosis.
Numb protein was first observed in Drosophila [39]
and is thought to be a cell fate determinant that acts by
regulating cell division, adhesion, and migration [40] In
mammals, Numb protein inhibits Notch signaling by pro-
moting the ubiquitination of the Notch1 receptor and the
degradation of Notch1 intracellular domain (NICD) [16].
Numb is considered a tumour suppressor [41] in various
carcinomas, including breast cancer [42] and salivary
gland carcinomas [43]. However,Numb overexpression
has been observed in astrocytomas [44] and cervical squa-
mous carcinoma cells [45], implying that Numb may be
oncogene in these diseases. In the current study, we inves-
tigated Numb expression in normal endometrium and
adenomyotic endometrium, and we found that Numb
expression did not change during the menstrual cycle in
either normal endometria or adenomyotic endometria, in-
dicating that Numb expression is hormonally independ-
ent. In addition, the loss of Numb expression was noted in
adenomyosis, demonstrating that aberrant negative regu-
lation of Numb may be involved in the genesis and devel-
opment of adenomyosis. To our knowledge, the current
study is the first to explore the role of Numb in
adenomyosis.
EMT is activated by a number of transcription factors,
including Snail, Slug, and Twist, and also by the repres-
sion of E-cadherin expression [46]. Snail and Slug have
been reported to be associated with tumour cell migration,
invasion, and metastasis. Snail was first discovered in
Drosophila as a zinc-finger transcription factor and has
since been proven to be a key regulator of EMT [47]. Snail
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E-box site in the promoter of E-cadherin [48]. The role of
Snail in EMT regulation has been reported in multiple
carcinoma types, including breast carcinoma, ovarian car-
cinoma, etc. [48, 49]. Slug, which belongs to the Slug family
of zing-finger transcription factors, also plays a major role
in EMT during embryonic development and metastasis of
various cancers by inhibiting E-cadherin [50]. In ovarian
carcinoma cells, increased expression of Snail and Slug
directly lead to cisplatin resistance [51] and promote the
EMT process by activating theβ-Catenin–T-Cell Factor-4-
dependent expression of transforming growth factor-β3
[52]. Functional knockdown of Snail and Slug was shown
to significantly decrease the tumourigenicity and metastatic
behaviour of squamous carcinoma cells [53]. In the current
study, we discovered that Snail and Slug were upregulated
in adenomyosis, indicating the possible role of Snail/Slug-
associated EMT in the pathogenesis and development of
adenomyosis. In addition, Snail expression changed during
the menstrual cycle in normal endometria, but Slug expres-
sion did not change during the menstrual cycle in either
normal endometria or adenomyotic endometria. Further-
more, the menstrual changes in Snail expression were ab-
sent in adenomyosis, suggesting the decreased hormonal
sensitivity of the ectopic endometrium of adenomyosis.
N-cadherin is another EMT marker. A switch from
expression of E-cadherin to expression of N-cadherin is
frequently observed in many aggressive cancers [27]. N-
cadherin stimulates the upregulation of Snail and Slug in a
FGFR-dependent manner [54]. N-cadherin-mediated cell
adhesion accelerates cell migration in a three-dimensional
matrix [55]. In adenomyosis, we found that N-cadherin
was up-regulated in ectopic epithelial cells, indicating the
important role of N-cadherin in this disease. Moreover, N-
cadherin expression changed during the menstrual cycle
in normal endometrium but not in adenomyotic endomet-
rium. These data suggest decreased hormonal sensitivity
in adenomyosis.
One of the most common features of EMT is the loss of
E-cadherin expression [27]. During the EMT process, epi-
thelial cells undergo a phenotypic switch to the mesenchy-
mal phenotype, which leads to the loss of cell-cell adhesion,
alternation of polarity, modulation of the cytoskeletal sys-
tems, and a switch of expression from keratin to vimentin
[5]. Inhibition of Snail may stimulate the re-expression of
E-cadherin and other epithelial markers in metastatic tis-
sues, where higher expression of E-cadherin and epithelial
characteristics may contribute to increased survival and
proliferation [56]. In prostate cancer, E-cadherin and Snail
levels can be measured to assess disease prognosis and can
be used as therapeutic targets to prevent metastatic pro-
gression [57].A previous study reported that E-cadherin
expression was decreased in the uterus of mice and in hu-
man adenomyotic lesions [56]. Consistent with the resultsof Shih et al., in the current study, the expression of E-
cadherin was significantly reduced in ectopic epithelial cells
of adenomyotic endometrium. In addition, E-cadherin ex-
pression showed no hormonal dependence in normal endo-
metrium, while higher E-cadherin expression was noted in
adenomyotic endometrium in the proliferative phase com-
pared than in adenomyotic endometrium in the secretory
phase.
Conclusion
In conclusion, our data demonstrate the possible involve-
ment of Notch1/Snail/Numb signaling in the pathogenesis
and development of adenomyosis (Fig. 7). The current
study may provide new insight into the diagnosis and
treatment of adenomyosis.However, the main limitation of
this study is that we only examined the expression and
location of Notch1/Numb/Snail signaling by immunohis-
tochemistry. In our next study, our team will examine the
involvement of Notch1 signaling in adenomyosis using
multiple experimental techniques.
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